Kel's Pharmaceutical Service LLC is categorized under Services (Unclassified) in Grand Prairie, TX and active since 2012.
Kel's Pharmaceutical Service LLC was established in 2012, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 541990 by the NAICS.
If you are seeking more information, feel free to contact Roy K Nwakamma at the company’s single location by writing to 2024 Limestone Drive, Grand Prairie, Texas TX 75052 or by phoning (972) 522-1889. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Kel's Pharmaceutical Service LLC |
| Contact Person: | Roy K Nwakamma |
| Address: | 2024 Limestone Drive, Grand Prairie, Texas 75052 |
| Phone Number: | (972) 522-1889 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Services (Unclassified) |
| SIC Code: | 8999 |
| NAICS Code: | 541990 |
| Share This Business: |
Kel's Pharmaceutical Service LLC was started in 2012 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 541990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Roy K Nwakamma for inquiries that concern Kel's Pharmaceutical Service LLC by calling the company number (972) 522-1889, as your correspondence is most welcome. Additionally, the physical location of the single location of Kel's Pharmaceutical Service LLC can be found at the coordinates 32.642419,-97.031996 as well as the street address 2024 Limestone Drive in Grand Prairie, Texas 75052.
For its online presence, you may visit Kel's Pharmaceutical Service LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.